Blood Screening Market Size, Share, Growth, Trends and Forecast 2030
.jpg){kind=logo}
Blood Screening Market Overview
The global blood screening market is a
continually growing space. The market growth attributes to the rising blood
screening procedures conducted for the diagnosis of various chronic diseases
such as HIV, HCV, HBV, malaria, syphilis, and other infectious diseases.
Besides, increasing screening tests conducted on the donated blood to lessen
the risk of transfusion-transmitted infections (TTIs) foster the market growth
excellently. Moreover, raising awareness about the importance of blood tests
escalates market growth.
According to Market Research Future (MRFR), the
global Blood Screening Market is estimated to
grow at 8.10% CAGR during the forecast period (2022–2030). Due to the
complexity of Coronaviruses, numbers of blood screening tests are increasing.
Besides, the immune biomarker test used in the treatment of COVID 19 to
identify and quantify the human immune system’s response to the virus influence
the growth of the market. Also, increasing numbers of blood donations and blood
donors is a significant growth driver of the market.
Additionally, increasing per capita healthcare
expenditures and the adoption of nucleic acid test (NAT) for blood screening,
boost the growth of the market. The introduction of pathogen reduction
technology and the demand of multiplex tests propel the market growth.
Conversely, factors such as the high costs and lack of regulations for NAT
devices are estimated to restrict the growth of the market. Also, the advent of
alternative technologies limits the market growth.
Blood Screening Market Segmentation
The
worldwide market for blood screening has been segmented on the technology,
products & services and end-users.
Depending
on the technology, the market has been classified into nucleic acid
amplification test (NAT), enzyme-linked immunosorbent assay (ELISA), rapid
tests, next-generation sequencing (NGS), western blotting.
With
respect to products and services, the market is considered for reagent and
kits, enzymes and polymerases, standards and controls, probes and primers,
buffers, nucleotides, and solutions, immunosorbents, instruments and software,
and services.
The
various end users in the market are hospitals, clinics, research institutes and
academic centers, blood banks and others.
Blood Screening Market Regional Analysis
In
context of region, the worldwide blood screening market is split into the key
regions of Europe, Asia Pacific, the Middle East and Africa and North America.
North
America, with the biggest share in the global market, benefits from the early
adoption of cutting-edge medical technologies and continuous development of
latest drug by several companies. The America’s Blood organization says that 1
in 7 people who visit hospitals require blood. The American Red Cross suggests
that less than 38 percent of the total regional population can give blood or
platelets. Furthermore, the Centers for Disease Control and Prevention (CDC)
reveals that, in the United States (U.S.), there are over 9.5 million blood
donors and close to 5 million patients that receive blood every year, leading
to a total of 14.6 million transfusions annually.
The
Europe blood screening market stands with the second largest share, backed by
the rise in research expenses and the constant advancement of technology. Along
with the decline in human health in the region, the need for sophisticated and
effective therapies has added to the strength of the market. The World Health
Organization (WHO) says that the average number of donations in the European
Region is between 6 and 67.6 per 1000 inhabitants, where Demark boasts of the
highest blood donation rate.
The
Asia Pacific market can anticipate favorable growth in the future, owing to the
availability of optimal treatment facilities paired with the increasing number
of government initiatives. Presence of advanced technology, improved adoption
rate, and surging healthcare expenditure are other critical factors deciding
the market fate. India and China are considered the hotspots for investment
opportunities because of the large number of research activities along with the
number of partnerships. Of course, growing success rate of diagnosis, healthcare
modernization, and quality improvisations have a big hand in the market growth
as well.
Middle
East & Africa has the smallest share in the global market compared to other
regions, owing to the substandard healthcare sector, scanty technical
knowledge, and poor medical facilities.
Esteemed Vendors
Blood Screening Market Players are Abbott
Laboratories, Ortho Clinical Diagnostics, Inc., Thermo Fisher Scientific, Inc.,
F. Hoffmann-La Roche, Beckman Coulter (A Subsidiary of Danaher Corporation),
Becton, Dickinson and Company Market Grifols, Biomérieux, Bio-Rad Laboratories,
Inc., Siemens Healthineers (A Subsidiary of Siemens AG), to name a few.
At Market Research Future (MRFR), we enable our customers
to unravel the complexity of various industries through our Cooked Research
Report (CRR), Half-Cooked Research Reports (HCRR), & Consulting Services.
MRFR team have supreme objective to provide the optimum quality market research
and intelligence services to our clients.
Contact us:
Market Research Future (part of Wantstats Research and
Media Private Limited),
99 Hudson Street, 5Th Floor,
New York, New York 10013
United States of America
+1 628 258 0071
Email: sales@marketresearchfuture.com
Comments
Post a Comment